CAMBRIDGE, Mass.--(BUSINESS WIRE)--

Good Start Genetics, Inc.,an innovative molecular diagnostics company developing the new gold standard in carrier screening, announced today that it will present a company overview at the Cowen and Company 33rd Annual Health Care Conference at the Boston Marriott Copley Place. Don Hardison, president and CEO of Good Start Genetics, is scheduled to present at 9 a.m. on Tuesday, March 5.

Mr. Hardison will provide an overview of Good Start Genetics and its groundbreaking next-generation DNA sequencing based carrier screening service, as well as highlights from its first year on the market. Mr. Hardison will be available to meet with investors and media attending the conference.

Good Start Genetics recently announced that four separate abstracts related to its technology have been accepted for presentation at the upcoming annual meetings of the Pacific Coast Reproductive Society (PCRS) and the American Congress of Medical Genetics and Genomics (ACMG).

Since its national launch in April 2012, Good Start Genetics high-complexity, CLIA- and CAP-accredited laboratory has processed tens of thousands of test orders. The GoodStart Select next-generation gene sequencing technology detects common mutations in carriers across all 23 diseases recommended for testing by major medical societies as well as rare mutations that would go undetected by laboratories using older, traditional genotyping-based technologies. For example, most genotyping technologies detect about 100 mutations for cystic fibrosis (CF), while GoodStart Select detects 550 mutations.

Event

Date

Time

Place

About Good Start Genetics, Inc.

Continued here:
Good Start Genetics to Present at Cowen and Company 33rd Annual Health Care Conference

Comments are closed.